BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26659818)

  • 1. Neonatal Abstinence Syndrome Following Tianeptine Dependence During Pregnancy.
    Bence C; Bonord A; Rebillard C; Vaast P; Alexandre C; Jardri R; Rolland B
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26659818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Opioid Withdrawal Syndrome Following Prenatal Use of Supplements Containing Tianeptine.
    Ikeri K; Anderson A; Eyal F; Whitehurst R
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38213293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it possible to be dependent to Tianeptine, an antidepressant? A case report.
    Kisa C; Bulbul DO; Aydemir C; Goka E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):776-8. PubMed ID: 17270334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Buprenorphine-Naloxone in the Treatment of Tianeptine Use Disorder.
    Trowbridge P; Walley AY
    J Addict Med; 2019; 13(4):331-333. PubMed ID: 30550394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
    Jones HE; Fielder A
    Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
    Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
    Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
    Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
    Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and NAS: does sex matter?
    Holbrook A; Kaltenbach K
    Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
    Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
    J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tianeptine Abuse and Dependence in Psychiatric Patients: A Review of 18 Case Reports in the Literature.
    Springer J; Cubała WJ
    J Psychoactive Drugs; 2018; 50(3):275-280. PubMed ID: 29494783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianeptine Abuse and Dependence: Case Report and Literature Review.
    Lauhan R; Hsu A; Alam A; Beizai K
    Psychosomatics; 2018 Nov; 59(6):547-553. PubMed ID: 30149933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal abstinence syndrome after maternal use of tramadol].
    de Wit D; Koomen-Botman I
    Ned Tijdschr Geneeskd; 2013; 157(9):A5610. PubMed ID: 23446156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of neonatal abstinence syndrome in a community hospital.
    Napolitano A; Theophilopoulos D; Seng SK; Calhoun DA
    Clin Obstet Gynecol; 2013 Mar; 56(1):193-201. PubMed ID: 23314713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.
    Samuels BA; Nautiyal KM; Kruegel AC; Levinstein MR; Magalong VM; Gassaway MM; Grinnell SG; Han J; Ansonoff MA; Pintar JE; Javitch JA; Sames D; Hen R
    Neuropsychopharmacology; 2017 Sep; 42(10):2052-2063. PubMed ID: 28303899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery and management of a preterm infant in the burn unit: a multidisciplinary approach.
    Rodriguez O; Cooma R; Cooper M; Roth P
    Burns; 2015 May; 41(3):e51-5. PubMed ID: 25704835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of tianeptine use in patients with epilepsy.
    Moon J; Jung KH; Shin JW; Lim JA; Byun JI; Lee ST; Chu K; Lee SK
    Epilepsy Behav; 2014 May; 34():116-9. PubMed ID: 24739449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.